Table 2.
Semi-quantitative data on U.S. pharmacist insights into HPV vaccination in eight states among HPV vaccine providers (n = 18).
| n (%) | |
|---|---|
| Challenges to providing HPV vaccines to adolescents* | |
| Parental consent | 5 (28) |
| Tracking and recall of patients | 3 (17) |
| Education/promotion of vaccination | 3 (17) |
| Stigma about vaccination among parents of adolescents | 3 (17) |
| Cost of vaccination | 2 (11) |
| Potential adverse reactions | 2 (11) |
| State laws | 1 (6) |
| Don’t know | 1 (6) |
| None | 3 (17) |
| Strategies to overcome challenges of providing HPV vaccination † | |
| Providing education or support to patient and patient’s guardian | 4 (22) |
| Reminder system for patients of upcoming doses | 1 (6) |
| Facilitators towards success of HPV vaccination program in pharmacy* | |
| Clear guidelines from pharmacy/corporate management | 4 (22) |
| State legislative authority to provide vaccination | 3 (17) |
| Promotion outside pharmacy | 3 (17) |
| Education or promotion within pharmacy | 3 (17) |
| Reimbursement of adolescent vaccines | 2 (11) |
| Designated space for vaccination | 1 (6) |
| Student vaccination | 1 (6) |
| Having vaccines in stock | 1 (6) |
| Not applicable‡ | 4 (22) |
| Don’t know | 3 (17) |
| Comfort level administering HPV vaccines to adolescents§ | |
| Very comfortable | 14 (78) |
| Somewhat comfortable | 3 (17) |
| Somewhat uncomfortable | 1 (6) |
* Totals may exceed 100%, multiple answers possible
† Only 27% (n = 5) of pharmacists reported ways to overcome challenges
‡ Pharmacists described their HPV vaccination program as unsuccessful
§ Pharmacists were given the following options: very comfortable, somewhat comfortable, neutral, somewhat uncomfortable, and very uncomfortable
Abbreviations: Human papillomavirus (HPV), United States (U.S.)